Immunofluorescence staining also revealed that LV-Nanog-siRNA could retard pulmonary fibroblast activation in BLM-induced pulmonary fibrosis, as confirmed by decreased expression of α-SMA and collagen I (Figure 6G). The gene discussed is ACTA1; the disease is pulmonary fibrosis.